Generic drug approvals surge by 20% within 9 months of Makary's exit

Makary was known for prioritizing innovative drugs, so his absence may accelerate generic drug reviews to meet demand. Generic approvals have historically risen 15-25% in similar scenarios.

Implied probability (Yes)

60%